NHTC NATURAL HEALTH TRENDS CORP
Wholesale-Miscellaneous Nondurable Goods · Nasdaq · SEC CIK 912061 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-16.5%
TTM net income YoY-1,107.6%
TTM EPS YoY-1,300.0%
Revenue 3-yr CAGR-9.1%
Net income 3-yr CAGR—
Margins
Gross margin74.3%
Operating margin-5.9%
Net margin-4.2%
FCF margin-13.7%
EBITDA margin-5.7%
Returns
ROE-6.9%
ROA-4.1%
ROIC (approx.)-15.3%
Asset turnover0.98x
Leverage & solvency
Liabilities / assets45.0%
Debt / equity0.00x
Current ratio2.13x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.96x
Accruals ratio8.0%
Payout ratio—
Capex / revenue1.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $39.78M | $42.96M | $43.92M | $49.13M | $60.01M |
| Cost of revenue | $10.52M | $11.18M | $11.18M | $12.66M | $15.01M |
| Gross profit | $29.25M | $31.79M | $32.75M | $36.47M | $44.99M |
| SG&A expense | $14.76M | $15.51M | $16.01M | $16.00M | $17.85M |
| Operating income | -$1.81M | -$1.30M | -$1.67M | -$270,000 | $1.57M |
| Pretax income | -$567,000 | $620,000 | $745,000 | $602,000 | $1.51M |
| Income tax | $315,000 | $48,000 | $177,000 | $289,000 | $425,000 |
| Net income | -$882,000 | $572,000 | $568,000 | $313,000 | $1.08M |
| EBITDA | -$1.70M | -$1.17M | -$1.51M | -$66,000 | $1.87M |
| EPS (basic) | -0.08 | 0.05 | 0.05 | 0.03 | 0.10 |
| EPS (diluted) | -0.08 | 0.05 | 0.05 | 0.03 | 0.09 |
| Dividends declared per share | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 |
| Weighted avg. shares (diluted) | 11.50M | 11.49M | 11.46M | 11.42M | 11.42M |
| Balance sheet | |||||
| Cash & equivalents | $6.81M | $13.53M | $56.18M | $69.67M | $83.84M |
| Short-term investments | $22.06M | $30.41M | $0 | — | — |
| Inventory | $2.05M | $3.27M | $4.29M | $4.53M | $5.26M |
| Current assets | $34.19M | $50.98M | $64.23M | $77.55M | $93.47M |
| PP&E, net | $153,000 | $190,000 | $266,000 | $394,000 | $463,000 |
| Total assets | $38.43M | $55.36M | $69.09M | $82.82M | $98.36M |
| Current liabilities | $13.69M | $20.80M | $19.98M | $20.44M | $24.66M |
| Total liabilities | $15.00M | $22.49M | $27.49M | $32.67M | $38.87M |
| Shareholders' equity | $23.43M | $32.87M | $41.60M | $50.15M | $59.49M |
| Cash flow statement | |||||
| Operating cash flow | -$6.00M | -$3.37M | -$4.28M | -$4.85M | $1.02M |
| Capital expenditure | $68,000 | $57,000 | $46,000 | $143,000 | $225,000 |
| Free cash flow | -$6.07M | -$3.42M | -$4.32M | -$5.00M | $791,000 |
| Investing cash flow | $8.15M | -$30.07M | -$46,000 | -$143,000 | -$225,000 |
| Financing cash flow | -$9.21M | -$9.21M | -$9.21M | -$9.14M | -$9.14M |
| Depreciation & amortization | $109,000 | $131,000 | $164,000 | $204,000 | $299,000 |
| Stock-based compensation | $132,000 | $145,000 | $161,000 | $0 | — |
| Dividends paid | $9.21M | $9.21M | $9.21M | $9.14M | $9.14M |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.